# Radiometer

Radiometer is a Private Equity based in Bronshoj, Denmark.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Bronshoj, Denmark
- **Region:** Europe
- **Address:** Bronshoj, Denmark
- **Founded:** 1954
- **Assets under management:** Undisclosed
- **Website:** www.radiometer.com
- **LinkedIn:** linkedin.com/company/radiometer

## Regulatory record

- **Reports private funds:** No

## About

Radiometer is a medical device company that develops products and solutions for acute care diagnostics. It integrates blood gas analyzers, syringes, point-of-care IT, and services to streamline diagnostic workflows for critically ill patients. The company pioneered the blood gas market and developed the world’s first commercially available blood gas analyzer in 1954. It is part of Danaher Corporation and has more than 4,500 associates.

## Sectors

- Healthcare Services
- Diagnostics & Research Tools

## People

- Davide Manissero — Vice President and Chief Medical Officer
- Jamie Acero — Medical Science Liaison

## Questions

### What is Radiometer's primary business and revenue model?

Radiometer develops, manufactures and sells point-of-care diagnostic instruments and consumables for acute care settings. Its revenue model centers on the placement of blood gas and immunoassay analyzer platforms, which generate recurring income through proprietary reagent packs, syringes, sampling supplies and IT management software subscriptions. The firm's commercial footprint spans emergency departments, ICUs and neonatal intensive care units.

### Does Radiometer make private equity or venture capital investments?

Radiometer is classified as an asset manager in certain databases, but it does not operate as a private equity firm or venture capital investor. Its capital is deployed into research, manufacturing, distribution and digital infrastructure to support its own diagnostic product line. There is no publicly disclosed portfolio of third-party fund commitments, direct co-investments or external company stakes.

### How does Radiometer source and retain hospital clients?

The firm leverages a direct sales force and a partner channel program to distribute analyzers and consumables into global markets. Client retention is structurally embedded through proprietary reagent and consumable lock-in linked to the installed base of Radiometer analyzers. Dedicated point-of-care IT solutions, such as those referenced in case studies with La Paz University Hospital in Spain, further integrate the firm into hospital workflows and regulatory compliance processes.

### Which patient care departments does Radiometer explicitly serve?

Radiometer segments its solutions for emergency care, intensive care and neonatal intensive care. Its website explicitly markets distinct analyzer configurations, data management modules and sampling workflows tailored to each department's clinical decision-making timelines and blood conservation requirements. There is no publicly stated focus on general ward diagnostics or primary care settings.

### What is the firm's geographic footprint and distribution strategy for emerging markets?

Radiometer sells products in over 100 countries through a mix of direct commercial operations and a channel partner program. The firm actively recruits local partners to represent it in regions where it lacks a direct subsidiary. Specific named countries beyond Denmark are not enumerated on the website, though clinical case studies reference installations in France and Spain.

## Related profiles

- [Radiology Associates, P.A. Profit Sharing Plan](https://altss.com/profile/radiology-associates-p-a-profit-sharing-plan)
- [Radio Telefís Éireann Pension Fund](https://altss.com/profile/radio-telef-s-ireann-pension-fund)

---

Last updated: 2026-08-11T15:07:49.000Z

Canonical page: https://altss.com/profile/radiometer

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology